Evaluation of the association between the CYP19 tetranucleotide (TTTA) n polymorphism and Polycystic Ovarian Syndrome(PCOS) in Han Chinese women

Neuroendocrinology Letters

Volumn 31, Issue 3, 2010, Pages 370-374

  Hao, Cui Fang ^a   Zhang, Ning ^a   Qu, Qinglan ^a   Wang, Xiong ^a   Gu, Harvest F ^b   Chen, Zi Jiang ^c  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SHANDONG UNIVERSITY   (China)

Author keywords

CYP19; Genetic association; Polycystic ovarian syndrome; Tetranucleotide polymorphism

Indexed keywords

AROMATASE; LOW DENSITY LIPOPROTEIN; NUCLEOTIDE; TETRANUCLEOTIDE; UNCLASSIFIED DRUG; MICROSATELLITE DNA;

ADULT; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS;

ADULT; AROMATASE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MICROSATELLITE REPEATS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC;

EID: 77955443384     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Baghaei F, Rosmond R, Landén M, Westberg L, Hellstrand M, Holm G, Eriksson E, et al. (2003). Phenotypic and genotypic characteristics of women in relation to personality traits. Int J Behav Med. 10(4): 365-378.
2. Carlsson E, Poulsen P, Storgaard H, Almgren P, Ling C, Jensen CB, Madsbad S, et al. (2005). Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. Diabetes. 54: 3015-3020.
3. Chen SA, Besman MJ, Sparkes RS, Zollman S, Klisak I, Mohandas T, Hall PF, et al. (1988). Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. DNA. 7(1): 27-38.
4. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF 2nd & Fitzpatrick LA (2003). Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 88: 2562-2568. (Pubitemid 36724424)
5. Diamanti-Kandarakis E, Bartzis MI, Bergiele AT, Tsianateli TC, Kouli CR (2000). Microsatellite polymrophism (tttta) at -528 base pairs of gene CYP11a infleunecs hyperandrogenemia in patients with polycystic ovary syndrome. Fertile Steril. 73: 735-741.
6. Diamanti-Kandarakis E, Kandarakis H, Legro RS (2006). The role of genes and enviroment in the etiology of PCOS. Endocrine. , 30: 19-26.
7. Franks S, McCarthy MI, Hardy K (2006). Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Andrology. 29: 278-285.
8. Fratantonio E, Vicari E, Pafumi C & Calogero AE (2005). Genetics of polycystic ovarian syndrome. Reprod Biomed Online. 10: 713-720. (Pubitemid 40796936)
9. Gaasenbeek M, Powell BL, Sovio U, Haddad L, Gharani N, Bennett A, Groves CJ, et al. (2004). Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. Clin Endocrinol Metab. 89: 2408-2413.
10. Gharani N, Waterworth DM, Batty S, White D, Gilling-Smith C, Conway GS, McCarthy M, et al. (1997). Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet. 6: 397-402. (Pubitemid 27116459)
11. Ito Y, Fisher CR, Conte FA, Grumbach MM and Simpson ER (1993). Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA. 90: 11673-11677.
12. Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA (1998). Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod. 4(1): 1-8.
13. Jakubowski L (2005). Genetic aspects of polycystic ovary syndrome. Endokrynol Pol. 56(3): 285-93.
14. Legro RS (2003). Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 24: 302-312.
15. Ovalle F & Azziz R (2002). Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus. Fertil Steril. 77: 1095-1105. (Pubitemid 34626313)
16. Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Baien AH, Zegher F, et al. (2005). Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod. 20(7): 1837-1843.
17. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, et al. (1994). Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 5(3): 342-355.
18. Su Y. Polycystic ovary syndrome: In Zhang L (2001). Clinical reproductuve endocrinology. Beijing, Chinese Scientific. pp: 367-399.
19. Söderlund D, Canto P, Carranza-Lira S, Méndez JP (2005). No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Hum Reprod. 20(4): 965-969.
20. Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF, Tomer Y (2001). Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab. 86(1): 446-449.
21. Wang Y, Wu X, Cao Y, Yi L, Chen J (2006). A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome. Fertil Steril. 86: 223-226. (Pubitemid 43962960)